Did you catch the recent NBC News article about Candida auris, which has been a top concern of health officials for several years? Per the CDC, it is an emerging fungus that presents a serious global health threat.
The CDC is concerned about C. auris for three main reasons:
It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida infections. Some strains are resistant to all three available classes of antifungals.
- It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.
It has caused outbreaks in healthcare settings. For this reason, it is important to quickly identify C. auris in a hospitalized patient so that healthcare facilities can take special precautions to stop its spread.
NEL has partnered with CHROMagar™ of France, the original and leading developer of chromogenic media, to bring Colorex™ Candida Plus to the United States. Colorex™ Candida Plus plates are made in the U.S., using CHROMagar's globally praised proprietary components. These prepared culture plates are a key step in detecting Candida auris.